Actively Recruiting
Randomized Controlled Trial Comparing Iheezo Chloroprocaine HCl Ophthalmic Gel 3% Versus Subconjunctival Lidocaine 2% for Pain Reduction in Intravitreal Injections
Led by Retina Research Institute, LLC · Updated on 2026-10-26
80
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, randomized, controlled trial to compare pain levels experienced by patients after intravitreal injections when using two different anesthetics Iheezo Chloroprocaine HCl ophthalmic gel 3% and subconjunctival Lidocaine 2%. The study aims to determine if Iheezo is not inferior to Lidocaine in reducing pain up to 24 hours post-injection. The trial is sponsored by Retina Research Institute, LLC and involves about 80 participants. Participants will be randomly assigned to receive either Iheezo, a topical anesthetic gel, or subconjunctival Lidocaine, an injection anesthetic, before their intravitreal injection procedure. Both treatments are approved for pre-procedure anesthesia. The study uses a parallel design with double masking to assess and compare the pain scores associated with each anesthetic over the 24-hour period following the injection. During the study, participants will undergo intravitreal injections with one of the study anesthetics, and their pain levels will be measured up to 24 hours afterward. The primary outcome is pain scores assessed at 4 hours post-injection. Participants will be monitored throughout the study period to collect these pain assessments. The total duration of participation spans from screening through the completion of the post-injection evaluation.
CONDITIONS
Brief Title
Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial
Research Team
A
Allan Braverman, B.S.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here